Pharscin Pharma(SZ:002907) Shang Hai Zheng Quan Bao·2025-09-05 21:29Core Viewpoint - Chongqing Huasen Pharmaceutical Co., Ltd. has received the approval notice for the supplementary application of Jian'er Xiaoshi Oral Liquid, marking the company as the holder of the drug marketing license, which is expected to enhance its product pipeline and expand its retail market presence [1][4]. Group 1: Drug Information - Jian'er Xiaoshi Oral Liquid is indicated for strengthening the spleen and stomach, regulating qi, and aiding digestion, particularly for children suffering from poor appetite and digestive issues due to irregular eating habits [2][3]. - The recommended dosage is 5-10 milliliters for children under 3 years old and 10-20 milliliters for those over 3 years, administered twice daily [2]. Group 2: Market Context - The pediatric traditional Chinese medicine market has been steadily growing, with sales reaching 18.3 billion yuan in 2024. Public hospitals account for 50.1% of sales, while retail pharmacies contribute 37% [3]. - Pediatric appetite disorder medications dominate the pediatric traditional Chinese medicine market, with Jian'er Xiaoshi Oral Liquid being a common choice due to its safety and palatable taste [3]. Group 3: Company Impact - The approval of Jian'er Xiaoshi Oral Liquid will enrich the company's product offerings and enhance its sales in the pediatric digestive field, contributing to sustainable development [4]. - The company plans to initiate marketing efforts promptly following the approval [4].